412348-27-7 Usage
Uses
Used in Pharmaceutical Industry:
Tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate is used as a key intermediate in the synthesis of various drugs and bioactive molecules. Its unique structure allows for the development of compounds with specific therapeutic targets, making it a versatile component in medicinal chemistry.
Used in Drug Development:
As a building block for new drugs, tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate is utilized for the creation of pharmaceuticals with potential applications in treating neurological and psychiatric disorders. Its structural features facilitate the design of molecules that can interact with specific receptors or enzymes, contributing to the advancement of treatment options for these conditions.
Used in Coordination Chemistry:
The bromopyridin-3-yl group present in tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate suggests its use as a ligand in coordination chemistry. This application allows for the exploration of its binding properties with various metal ions, potentially leading to the discovery of new coordination compounds with specialized functions.
Used in Chemical Modification and Functionalization:
Tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate serves as a precursor for further chemical modification and functionalization. This enables the synthesis of a range of derivative compounds with tailored properties, expanding the scope of its applications in various fields, including materials science and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 412348-27-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,2,3,4 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 412348-27:
(8*4)+(7*1)+(6*2)+(5*3)+(4*4)+(3*8)+(2*2)+(1*7)=117
117 % 10 = 7
So 412348-27-7 is a valid CAS Registry Number.
412348-27-7Relevant academic research and scientific papers
UREA DERIVATIVES AS INHIBITORS OF ASK1
-
Paragraph 0158, (2019/06/05)
The present technology is directed to compounds, compositions, and methods related to inhibition of ASK1. In particular, the present compounds (e.g., compounds of Formula I as defined herein) and compositions may be used to treat ASK1-mediated disorders and conditions, including, e.g., fibrotic diseases and acute and chronic liver diseases, among others.
